Home


NordicTrip


NBG-19-01; SWEBCG 19-01

A Translational Randomized phase III study

The recruitment is now completed!

Contact the Project coordinators for more information

Aim of the study
The goal of the study is to evaluate the pathologic complete response rate in patients with Triple Negative Breast Cancer receiving preoperative Platinum based Chemotherapy +- Capecitabine.

Collaborators

Representatives from:

SABO/SweBCG Sweden, PI Niklas Loman

DBCG Denmark, PI Bent Ejlertsen